These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


330 related items for PubMed ID: 16394173

  • 1. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a.
    Delhanty PJ, van der Eerden BC, van der Velde M, Gauna C, Pols HA, Jahr H, Chiba H, van der Lely AJ, van Leeuwen JP.
    J Endocrinol; 2006 Jan; 188(1):37-47. PubMed ID: 16394173
    [Abstract] [Full Text] [Related]

  • 2. Ghrelin regulates proliferation and differentiation of osteoblastic cells.
    Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C, Cocchi D.
    J Endocrinol; 2005 Jan; 184(1):249-56. PubMed ID: 15642801
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway.
    Delhanty PJ, van Koetsveld PM, Gauna C, van de Zande B, Vitale G, Hofland LJ, van der Lely AJ.
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E302-9. PubMed ID: 17405826
    [Abstract] [Full Text] [Related]

  • 6. Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects.
    Mazzocchi G, Neri G, Rucinski M, Rebuffat P, Spinazzi R, Malendowicz LK, Nussdorfer GG.
    Peptides; 2004 Aug; 25(8):1269-77. PubMed ID: 15350694
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. GH-releasing peptides and bone.
    Cocchi D, Maccarinelli G, Sibilia V, Tulipano G, Torsello A, Pazzaglia UE, Giustina A, Netti C.
    J Endocrinol Invest; 2005 Aug; 28(8 Suppl):11-4. PubMed ID: 16323823
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
    Falls HD, Dayton BD, Fry DG, Ogiela CA, Schaefer VG, Brodjian S, Reilly RM, Collins CA, Kaszubska W.
    J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
    Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K, Palù G.
    Oncology; 2005 Aug; 68(4-6):414-21. PubMed ID: 16020971
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes.
    Iglesias MJ, Piñeiro R, Blanco M, Gallego R, Diéguez C, Gualillo O, González-Juanatey JR, Lago F.
    Cardiovasc Res; 2004 Jun 01; 62(3):481-8. PubMed ID: 15158140
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
    Muccioli G, Baragli A, Granata R, Papotti M, Ghigo E.
    Neuroendocrinology; 2007 Jun 01; 86(3):147-64. PubMed ID: 17622734
    [Abstract] [Full Text] [Related]

  • 16. Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells.
    De Vriese C, Delporte C.
    J Endocrinol; 2007 Jan 01; 192(1):199-205. PubMed ID: 17210757
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin, cortistatin, ghrelin and glucose metabolism.
    Gauna C, van der Lely AJ.
    J Endocrinol Invest; 2005 Jan 01; 28(11 Suppl International):127-31. PubMed ID: 16625861
    [Abstract] [Full Text] [Related]

  • 18. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
    Bresciani E, Tamiazzo L, Torsello A, Bulgarelli I, Rapetti D, Caporali S, Perrissoud D, Moulin A, Fehrentz JA, Martinez J, Locatelli V.
    Eat Weight Disord; 2008 Sep 01; 13(3):e67-74. PubMed ID: 19011367
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
    Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Evdokiou A, Atkins GJ.
    J Bone Miner Res; 2009 Aug 01; 24(8):1434-49. PubMed ID: 19292615
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.